Select your location
Wer bist du ?
Wählen Sie einen anderen Ort
Who are you ?
Select another location
Who are you ?
Select another location
Qui êtes vous ?
Sélectionnez un autre emplacement
Who are you ?
Select another location
Qui êtes vous ?
Sélectionnez un autre emplacement
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
Qui êtes vous ?
Sélectionnez un autre emplacement
Wer bist du ?
Wählen Sie einen anderen Ort
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
tu chi sei ?
Seleziona un'altra posizione
Wer bist du ?
Wählen Sie einen anderen Ort
Who are you ?
Select another location
Qui êtes vous ?
Sélectionnez un autre emplacement
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
Select another location
Quién eres tú ?
Seleccione otra ubicación
Who are you ?
Select another location
Wer bist du ?
Wählen Sie einen anderen Ort
Who are you ?
Select another location
Qui êtes vous ?
Sélectionnez un autre emplacement
Who are you ?
Select another location
Who are you ?
Select another location
Who are you ?
INSTITUTIONS
Select another location
Who are you ?
RETIREMENT PLAN INVESTOR
Use your plan ID (available on your account statement) to determine which employer-sponsored retirement plan website to use:
IF YOUR PLAN ID BEGINS WITH IRK, BRK, 754, 1 OR 2
Visit americanfunds.com/retire
IF YOUR PLAN ID BEGINS WITH 34 OR 135
Explorations
Cheryl Frank
Max Sasso
Laura Nelson Carney
The swift and successful development of COVID-19 vaccines is a feat of modern medicine ― not only raising hope for an eventual end to the coronavirus pandemic, but spotlighting the groundbreaking innovations that are transforming medicine today. These advances extend across a variety of diseases and hold enormous promise for patients, investors and global society.
Equity portfolio manager Cheryl Frank and biotechnology analyst Laura Nelson Carney provided a ground-level view of this emerging medical era.
Among the topics they discussed:
- The latest developments in the fight against COVID-19
- China’s rise as a global force in drug discovery
- Medical innovation in the coming decade
- What it all could mean for health care investing